天美传媒

Abstract

Endocrine complications arising from the use of immune checkpoint inhibitors present unique challenges in oncology and require specialized diagnostic and management strategies. This article provides a comprehensive overview of the diagnostic approaches and clinical management of endocrine side effects associated with immune checkpoint inhibitors. Key topics covered include the identification of symptoms, appropriate laboratory testing, differential diagnosis, and tailored treatment options. Emphasis is placed on early recognition of endocrine dysfunction to mitigate potential complications and improve patient outcomes. The aim is to equip healthcare professionals with practical guidelines for effectively managing endocrine issues related to immune checkpoint inhibitor therapy.